Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Appendix 5B

30 Oct 2020 07:05

RNS Number : 6370D
Danakali Limited
30 October 2020
 

Appendix 5B

Mining exploration entity or oil and gas exploration entityquarterly cash flow report

Name of entity

Danakali Limited

ABN

 

Quarter ended ("current quarter")

57 097 904 302

30 September 2020

 

Consolidated statement of cash flows

Current quarter$A'000

Year to date (9 months)$A'000

1.

Cash flows from operating activities

-

-

1.1

Receipts from customers

1.2

Payments for

-

-

(a) exploration & evaluation

(b) development

-

-

(c) production

-

-

(d) staff costs

(304)

(800)

(e) administration and corporate costs

(496)

(1,793)

1.3

Dividends received (see note 3)

-

-

1.4

Interest received

8

70

1.5

Interest and other costs of finance paid

-

-

1.6

Income taxes paid

-

-

1.7

Government grants and tax incentives

55

105

1.8

Other (provide details if material)

-

-

1.9

Net cash from / (used in) operating activities

(737)

(2,418)

2.

Cash flows from investing activities

-

-

2.1

Payments to acquire or for:

(a) entities

(b) tenements

-

-

(c) property, plant and equipment

-

-

(d) exploration & evaluation

-

-

(e) investments

-

-

(f) other non-current assets

-

-

2.2

Proceeds from the disposal of:

-

-

(a) entities

(b) tenements

-

-

(c) property, plant and equipment

-

-

(d) investments

-

-

(e) other non-current assets

-

-

2.3

Cash flows from loans to other entities

-

-

2.4

Dividends received (see note 3)

-

-

2.5

Other (funding of joint venture)

(2,097)*

(16,055)

2.6

Net cash from / (used in) investing activities

(2,097)

(16,055)

3.

Cash flows from financing activities

-

-

3.1

Proceeds from issues of equity securities (excluding convertible debt securities)

3.2

Proceeds from issue of convertible debt securities

-

-

3.3

Proceeds from exercise of options

-

-

3.4

Transaction costs related to issues of equity securities or convertible debt securities

-

(3,326)

3.5

Proceeds from borrowings

-

-

3.6

Repayment of borrowings

-

-

3.7

Transaction costs related to loans and borrowings

-

-

3.8

Dividends paid

-

-

3.9

Other (provide details if material)

-

-

3.10

Net cash from / (used in) financing activities

-

(3,326)

4.

Net increase / (decrease) in cash and cash equivalents for the period

4.1

Cash and cash equivalents at beginning of period

15,771

33,800

4.2

Net cash from / (used in) operating activities (item 1.9 above)

(737)

(2,418)

4.3

Net cash from / (used in) investing activities (item 2.6 above)

(2,097)

(16,055)

4.4

Net cash from / (used in) financing activities (item 3.10 above)

-

(3,326)

4.5

Effect of movement in exchange rates on cash held

(558)

378

4.6

Cash and cash equivalents at end of period

12,379

12,379

 

5.

Reconciliation of cash and cash equivalentsat the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

Current quarter$A'000

Previous quarter$A'000

5.1

Bank balances

12,379

8,501

5.2

Call deposits

-

-

5.3

Bank overdrafts

-

-

5.4

Other (term deposit)

-

7,270

5.5

Cash and cash equivalents at end of quarter (should equal item 4.6 above)

12,379

15,771

 

6.

Payments to related parties of the entity and their associates

Current quarter$A'000

6.1

Aggregate amount of payments to related parties and their associates included in item 1

104

6.2

Aggregate amount of payments to related parties and their associates included in item 2

-

Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.

Payments included in item 6.1 relates to payment of director fees ($104k)

7.

Financing facilitiesNote: the term "facility' includes all forms of financing arrangements available to the entity.

Add notes as necessary for an understanding of the sources of finance available to the entity.

Total facility amount at quarter end$A'000

Amount drawn at quarter end$A'000

7.1

Loan facilities

-

-

7.2

Credit standby arrangements

-

-

7.3

Other (please specify)

-

-

7.4

Total financing facilities

-

-

7.5

Unused financing facilities available at quarter end

-

7.6

Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.

 

 

 

 

8.

Estimated cash available for future operating activities

$A'000

8.1

Net cash from / (used in) operating activities (item 1.9)

(737)

8.2

 

8.2a

Payments for exploration & evaluation classified as investing activities (item 2.1(d))

Other (funding of joint venture) (item 2.5)

-

 

(2,097)*

8.3

Total relevant outgoings (item 8.1 + item 8.2 + item 8.2a)

(2,834)

8.4

Cash and cash equivalents at quarter end (item 4.6)

12,379

8.5

Unused finance facilities available at quarter end (item 7.5)

-

8.6

Total available funding (item 8.4 + item 8.5)

12,379

8.7

Estimated quarters of funding available (item 8.6 divided by item 8.3)

4.4

Note: if the entity has reported positive relevant outgoings (ie a net cash inflow) in item 8.3, answer item 8.7 as "N/A". Otherwise, a figure for the estimated quarters of funding available must be included in item 8.7.

* The Company considers it appropriate to include cash outflows related to the funding of joint venture (investing activities) in this table given its ongoing obligation to fund these activities.

8.8

If item 8.7 is less than 2 quarters, please provide answers to the following questions:

8.8.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?

Answer:

 

8.8.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?

Answer:

 

8.8.3 Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?

Answer:

 

Note: where item 8.7 is less than 2 quarters, all of questions 8.8.1, 8.8.2 and 8.8.3 above must be answered.

 

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.

2 This statement gives a true and fair view of the matters disclosed.

 

 

Date: 30 October 2020...............................................................

 

 

Authorised by: By the Audit and Risk Committee...............................

(Name of body or officer authorising release - see note 4)

 

Notes

1. This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity's activities for the past quarter, how they have been financed and the effect this has had on its cash position. An entity that wishes to disclose additional information over and above the minimum required under the Listing Rules is encouraged to do so.

2. If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standards apply to this report.

3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

4. If this report has been authorised for release to the market by your board of directors, you can insert here: "By the board". If it has been authorised for release to the market by a committee of your board of directors, you can insert here: "By the [name of board committee - eg Audit and Risk Committee]". If it has been authorised for release to the market by a disclosure committee, you can insert here: "By the Disclosure Committee".

5. If this report has been authorised for release to the market by your board of directors and you wish to hold yourself out as complying with recommendation 4.2 of the ASX Corporate Governance Council's Corporate Governance Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in their opinion, the financial records of the entity have been properly maintained, that this report complies with the appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZMZGMLNGGZM
Date   Source Headline
18th Sep 20197:27 amRNSProactive One2One Investor Forum presentation
13th Sep 20197:00 amRNSHY 2019 Financial Report
3rd Sep 20197:00 amRNSTotal Voting Rights and Capital
12th Aug 20197:00 amRNSAppendix 3B
12th Aug 20197:00 amRNSIssue of equity and total voting rights
12th Aug 20197:00 amRNSIssue of shares - s708A Notice
8th Aug 20197:00 amRNSCredit approval for Colluli power plant
5th Aug 20197:00 amRNSCredit approval for US$200M senior debt facility
1st Aug 20197:00 amRNSTotal Voting Rights
29th Jul 20197:00 amRNSQuarterly Report and Appendix 5B
15th Jul 20197:00 amRNSProactive Investors presentation
1st Jul 20197:00 amRNSTotal Voting Rights and Capital
28th Jun 20197:00 amRNSReport on Payments to Governments
14th Jun 20199:30 amRNSAppendix 3B
14th Jun 20199:30 amRNSNotification of PDMR and PCA Transactions
14th Jun 20199:30 amRNSAppendix 3Y - A Liebenberg
14th Jun 20199:30 amRNSIssue of Securities
14th Jun 20199:30 amRNSAppendix 3Y - S Cornelius
3rd Jun 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSReplacement Constitution
28th May 20197:00 amRNSResults of Annual General Meeting
10th May 20198:50 amRNSTR-1:Notification of Major Holdings
1st May 20197:00 amRNSTotal voting rights and capital
30th Apr 20197:00 amRNSQuarterly Report and Appendix 5B
24th Apr 20197:05 amRNSNotice of AGM
24th Apr 20197:00 amRNSNotification of PDMR transaction
24th Apr 20197:00 amRNSAppendix 3B
24th Apr 20197:00 amRNSIssue of Options
16th Apr 20197:09 amRNSRelease of 2018 Annual Report
2nd Apr 20197:00 amRNSTotal Voting Rights
26th Mar 20197:00 amRNSNotification of PCA transaction
26th Mar 20197:00 amRNSAppendix 3B
26th Mar 20197:00 amRNSIssue of options
25th Mar 20197:00 amRNSAppointment of new CEO
20th Mar 20197:00 amRNSDanakali 2018 Financial Report
7th Mar 20197:00 amRNSProactive Investors 121 Natural Resources Forum
4th Mar 20197:00 amRNSNotification of PCA transaction
4th Mar 20197:00 amRNSAppendix 3B
4th Mar 20197:00 amRNSIssue of Options
1st Mar 20197:02 amRNSTotal voting rights and capital
1st Mar 20197:00 amRNSChange of address
1st Feb 20197:00 amRNSTotal Voting Rights
31st Jan 20197:00 amRNSQuarterly Report and Appendix 5B
30th Jan 20197:00 amRNSUNDP report outlines potential for Colluli
3rd Jan 20197:00 amRNSUpdate on Issue of Equity and Total Voting Rights
21st Dec 20187:00 amRNSAppendix 3B
21st Dec 20187:00 amRNSIssue of Shares - s708A Notice
6th Dec 20187:00 amRNSUS$200m debt finance mandate executed
3rd Dec 20187:00 amRNSTotal Voting Rights
15th Nov 20187:00 amRNSResponse to Lifting of UN Sanctions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.